Riggenbach M, Haralambieva I, Ovsyannikova I, Schaid D, Poland G, Kennedy R
Clin Immunol. 2021; 234:108912.
PMID: 34968746
PMC: 8760162.
DOI: 10.1016/j.clim.2021.108912.
Lam E, Rosen J, Zucker J
Clin Microbiol Rev. 2020; 33(2).
PMID: 32102901
PMC: 7048016.
DOI: 10.1128/CMR.00151-19.
Can Commun Dis Rep. 2019; 36(Suppl 1):1-46.
PMID: 31680695
PMC: 6798733.
DOI: 10.14745/ccdr.v36i00as1.
Gallagher T, Lipsitch M
Epidemiol Rev. 2019; 41(1):13-27.
PMID: 31680134
PMC: 7159179.
DOI: 10.1093/epirev/mxz014.
Lewnard J, Grad Y
Sci Transl Med. 2018; 10(433).
PMID: 29563321
PMC: 5899613.
DOI: 10.1126/scitranslmed.aao5945.
Mumps Outbreak in a Highly Vaccinated University-Affiliated Setting Before and After a Measles-Mumps-Rubella Vaccination Campaign-Iowa, July 2015-May 2016.
Shah M, Quinlisk P, Weigel A, Riley J, James L, Patterson J
Clin Infect Dis. 2017; 66(1):81-88.
PMID: 29020324
PMC: 6827181.
DOI: 10.1093/cid/cix718.
Mumps antibody response in young adults after a third dose of measles-mumps-rubella vaccine.
Parker Fiebelkorn A, Coleman L, Belongia E, Freeman S, York D, Bi D
Open Forum Infect Dis. 2015; 1(3):ofu094.
PMID: 25734162
PMC: 4324223.
DOI: 10.1093/ofid/ofu094.
Mumps postexposure prophylaxis with a third dose of measles-mumps-rubella vaccine, Orange County, New York, USA.
Parker Fiebelkorn A, Lawler J, Curns A, Brandeburg C, Wallace G
Emerg Infect Dis. 2013; 19(9):1411-7.
PMID: 23965729
PMC: 3810923.
DOI: 10.3201/eid1909.130299.
Seroprevalence of measles-, mumps- and rubella-specific IgG antibodies in German children and adolescents and predictors for seronegativity.
Poethko-Muller C, Mankertz A
PLoS One. 2012; 7(8):e42867.
PMID: 22880124
PMC: 3412821.
DOI: 10.1371/journal.pone.0042867.
Immunizations in pediatrics: an update.
Ford-Jones E, Gold R
Can Fam Physician. 2011; 36:1555-61.
PMID: 21233925
PMC: 2280122.
Human leukocyte antigen and cytokine receptor gene polymorphisms associated with heterogeneous immune responses to mumps viral vaccine.
Ovsyannikova I, Jacobson R, Dhiman N, Vierkant R, Pankratz V, Poland G
Pediatrics. 2008; 121(5):e1091-9.
PMID: 18450852
PMC: 2668976.
DOI: 10.1542/peds.2007-1575.
Long-term persistence of mumps antibody after receipt of 2 measles-mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university population.
Date A, Kyaw M, Rue A, Klahn J, Obrecht L, Krohn T
J Infect Dis. 2008; 197(12):1662-8.
PMID: 18419346
PMC: 9169514.
DOI: 10.1086/588197.
Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England.
Cohen C, White J, Savage E, Glynn J, Choi Y, Andrews N
Emerg Infect Dis. 2007; 13(1):12-7.
PMID: 17370510
PMC: 2913658.
DOI: 10.3201/eid1301.060649.
Mumps virus-specific antibody titers from pre-vaccine era sera: comparison of the plaque reduction neutralization assay and enzyme immunoassays.
Mauldin J, Carbone K, Hsu H, Yolken R, Rubin S
J Clin Microbiol. 2005; 43(9):4847-51.
PMID: 16145156
PMC: 1234049.
DOI: 10.1128/JCM.43.9.4847-4851.2005.
Molecular identification of mumps virus genotypes from clinical samples: standardized method of analysis.
Palacios G, Jabado O, Cisterna D, de Ory F, Renwick N, Echevarria J
J Clin Microbiol. 2005; 43(4):1869-78.
PMID: 15815011
PMC: 1081370.
DOI: 10.1128/JCM.43.4.1869-1878.2005.
A review of licensed viral vaccines, some of their safety concerns, and the advances in the development of investigational viral vaccines.
Huang D, Wu J, Tyring S
J Infect. 2004; 49(3):179-209.
PMID: 15337336
PMC: 7126106.
DOI: 10.1016/j.jinf.2004.05.018.
[Mumps in a urban area of the Community of Madrid. Vaccination status, diagnosis and intervention measures].
de los Rios Martin R, Garcia Marin N, Moreno J, Ballester Orcal E
Aten Primaria. 2001; 28(1):10-6.
PMID: 11412572
PMC: 7681703.
DOI: 10.1016/s0212-6567(01)78889-0.
The control of mumps in Israel.
Slater P, Anis E, Leventhal A
Eur J Epidemiol. 1999; 15(8):765-7.
PMID: 10555621
DOI: 10.1023/a:1007663429371.
Mumps: a current epidemiologic pattern as a necessary background for the choice of a vaccination strategy.
Zotti C, Ossola O, Barberis R, Castella A, Ruggenini A
Eur J Epidemiol. 1999; 15(7):659-63.
PMID: 10543357
DOI: 10.1023/a:1007691509030.
Clinical economics: a method for prospective health resource data collection.
Kotsanos J, Conforti P, Franson T, Gordon G
Pharmacoeconomics. 1992; 1(5):370-6.
PMID: 10147001
DOI: 10.2165/00019053-199201050-00008.